Nuveen Asset Management, LLC Cullinan Oncology, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 227,033 shares of CGEM stock, worth $1.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

227,033

Previous 233,566 2.8%

Holding current value

$1.94 Million

Previous $3.91 Million 29.27%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$10.77 - $17.6 $70,360 - $114,980	-6,533 Reduced 2.8%	227,033 $2.77 Million
Q3 2024 Nov 14, 2024	BUY	$16.03 - $20.86 $253,274 - $329,588	15,800 Added 7.26%	233,566 $3.91 Million
Q2 2024 Aug 09, 2024	BUY	$15.63 - $29.35 $1.95 Million - $3.66 Million	124,544 Added 133.6%	217,766 $3.8 Million
Q1 2024 May 13, 2024	BUY	$10.17 - $19.02 $49,822 - $93,178	4,899 Added 5.55%	93,222 $1.59 Million
Q4 2023 Feb 14, 2024	BUY	$7.89 - $10.23 $76,588 - $99,302	9,707 Added 12.35%	88,323 $900,000

Q3 2023 Nov 14, 2023	BUY	$9.05 - $11.72 $11,810 - $15,294	1,305 Added 1.69%	78,616 $711,000
Q2 2023 Aug 14, 2023	BUY	$8.8 - $13.4 $44,906 - $68,380	5,103 Added 7.07%	77,311 $831,000
Q1 2023 May 15, 2023	SELL	$10.2 - $11.91 $209,589 - $244,726	-20,548 Reduced 22.15%	72,208 $738,000
Q4 2022 Feb 14, 2023	SELL	$9.72 - $13.62 $141,950 - $198,906	-14,604 Reduced 13.6%	92,756 $978,000
Q3 2022 Nov 14, 2022	BUY	$11.82 - $15.42 $15,921 - $20,770	1,347 Added 1.27%	107,360 $1.38 Million
Q2 2022 Aug 15, 2022	SELL	$7.31 - $13.55 $10,636 - $19,715	-1,455 Reduced 1.35%	106,013 $1.36 Million
Q1 2022 May 16, 2022	SELL	$10.47 - $16.75 $88,953 - $142,308	-8,496 Reduced 7.33%	107,468 $1.38 Million
Q4 2021 Feb 14, 2022	SELL	$15.36 - $25.0 $1.19 Million - $1.93 Million	-77,228 Reduced 39.97%	115,964 $1.79 Million
Q3 2021 Nov 12, 2021	BUY	$22.56 - $29.68 $1.58 Million - $2.07 Million	69,822 Added 56.6%	193,192 $4.36 Million
Q2 2021 Aug 16, 2021	BUY	$24.96 - $41.25 $1.84 Million - $3.04 Million	73,634 Added 148.05%	123,370 $3.18 Million
Q1 2021 May 17, 2021	BUY	$28.0 - $53.42 $1.39 Million - $2.66 Million	49,736 New	49,736 $2.07 Million

Others Institutions Holding CGEM

# of Institutions

149

Shares Held

65.1M

Call Options Held

10.7K

Put Options Held

14.4K

View Full List

About Cullinan Oncology, Inc.

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $390M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

More about CGEM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Cullinan Oncology, Inc. Transaction History